Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma
Meningiomas are primary CNS tumors that arise from the arachnoid layer of the meninges. Genomic sequencing has revealed that NF2 mutations are the most common genetic alteration seen in meningiomas. Meningiomas although usually low grade, can sometimes progress to high grade. A patient who had sever...
Main Authors: | Vinay Mathew Thomas, Poorva Bindal, James J. Vredenburgh |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-01-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/496984 |
Similar Items
-
RECURRENT MENINGIOMA AFTER INITIAL RESECTION SURGERY – CASE REPORT
by: Irene Davidescu, et al.
Published: (2015-12-01) -
Meningioma maligno Malignant meningioma
by: Yvei González Orlandi, et al.
Published: (2011-03-01) -
A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas
by: Maya Hrachova, et al.
Published: (2020-05-01) -
Intracranial – extracranial meningioma
by: Vuk Aleksic, et al.
Published: (2017-09-01) -
Evaluation of Contributive Factors onRecurrence of Intracranial Meningioma
by: Zeinab Ansari, et al.
Published: (2010-04-01)